Results 91 to 100 of about 2,823 (147)

Obicetrapib: There is still Life in the CETP Inhibitor! [PDF]

J Atheroscler Thromb
Ogura M.
europepmc   +1 more source

Are lipid-lowering drugs harmful to cognitive performance?: A Mendelian randomization study. [PDF]

Medicine (Baltimore)
Han L, Su C, Lian R, Han J, Fan X, Gao L.   +5 more
europepmc   +1 more source

Low HDL-The Challenge. [PDF]

Clin Med Res
Rezkalla SH, Kloner RA.
europepmc   +1 more source

A disproportionality analysis on proprotein convertase subtilisin/kexin type 9 inhibitors and hypersensitivity and anaphylaxis. [PDF]

Sci Rep
Dermiki-Gkana F, Gravel CA, Kontogiorgis C, Douros A.   +3 more
europepmc   +1 more source

<i>Proprotein Convertase Subtilisin</i>/<i>Kexin Type 9</i> (<i>PCSK9</i>) Inhibitor Therapy Reduces the Level of DNA Damage in Patients with Heterozygous Familial Hypercholesterolemia. [PDF]

Int J Mol Sci
Woźniak E, Woźniak A, Pawlos A, Broncel M, Satała J, Bukowska B, Gorzelak-Pabiś P.   +6 more
europepmc   +1 more source

LDL-C Goal Attainment with Fixed-Dose Ezetimibe and Atorvastatin Versus High-Dose Atorvastatin in Chinese Patients: Subgroup Analysis of a Randomized Trial. [PDF]

Adv Ther
Qian J, Zhang X, Chen J, Ding C, Yang P, Qing L, Liu Y, Chen SS, Ge J.   +8 more
europepmc   +1 more source

Physician Disagreement With Guidelines as a Critical Barrier to Achieving LDL-C Targets in Very High-Risk Patients: An Implementation Science Study. [PDF]

J Korean Med Sci
Cho KH, Cho YR, Lee SR, Bae JW, Nam CW, Park Y, Hwang JY, Yun KH, Kim W, Kim MC, Sim DS, Hong YJ, Kim JH, Ahn Y, Hahn JY, Jeong MH.   +15 more
europepmc   +1 more source

Attainment of low-density lipoprotein cholesterol goals in patients undergoing coronary revascularization in the contemporary clinical practice. [PDF]

Indian Heart J
Bansal M, Kasliwal RR, Chandra P, Kapoor R, Chouhan N, Bhan A, Trehan N.   +6 more
europepmc   +1 more source

Ezetimibe and the risk of new-onset type 2 diabetes: a systematic review and meta-analysis. [PDF]

Ann Med
Albawa'neh AS, Alqasrawi MN, Al-Mahayri ZN, Albawaana A, Ahmed G, Al-Rifai RH, Ali BR.   +6 more
europepmc   +1 more source

Treatment pathways of lipid-lowering therapies in Germany 2016-2022. [PDF]

Clin Res Cardiol
Katzmann JL, Grellmann C, Leppert B, Müller-Kozarez I, Schulz M, Laufs U.   +5 more
europepmc   +1 more source